Your Health, We Care

Home > Photo Wall > Honor and qualification

Production approval for Eltrombopag 50mg

Release date: 2024-07-10 13:56:26     Recommended: 86

05L0968_23 艾曲波帕50mg 批文_00.jpg

Etripopal is a type of thrombopoietin receptor agonist, suitable for treating thrombocytopenia in patients with chronic immune thrombocytopenic purpura. It is also suitable for patients with poor response to corticosteroids, immunoglobulins, or splenectomy.

Company News

Research News

Drug news